Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Acta cir. bras ; 28(3): 174-178, Mar. 2013. ilus, tab
Article in English | LILACS | ID: lil-667926

ABSTRACT

PURPOSE: To assess ischemic preconditioning (IPC) effects in pulmonary lesion in intestinal and hepatic ischemia-reperfusion (IR) injury models using diabetic rats. METHODS: Diabetes (DM) was induced in 28 male Wistar rats by alloxan (42 mg/kg, IV). After 28 days, severe DM rats were submitted to intestinal or hepatic IR injury with or without IPC. Intestinal IR (30 min of mesenteric artery occlusion and 30 min of reperfusion; n=6) and IPC groups (10 min ischemia, 10 min reperfusion, followed by intestinal IR; n=6), and Hepatic IR (30 min of hepatic pedicle occlusion and 30 min of reperfusion; n=5) and IPC groups (10 min ischemia, 10 min reperfusion, followed by hepatic IR; n=5), were compared to DM rats group (n=6). Plasmatic lactate, glycemia were measured before and after IR injury. Histomorphology of lung was performed counting inflammatory cells. Data was expressed in mean± SE. P<0.05. RESULTS: Glycemia and lactate were similar among groups. IPC did not interfere in these parameters. On histological evaluation, IR increased inflammatory cells infiltration in pulmonary parenchyma compared to control in both IR injury models. IPC attenuated inflammatory infiltration in lungs. CONCLUSION: Ischemic preconditioning protects against remote ischemia-reperfusion injury in lung on intestinal or hepatic ischemia-reperfusion model with acute diabetes.


Subject(s)
Animals , Male , Rats , Diabetes Mellitus, Experimental/physiopathology , Intestines/blood supply , Ischemic Preconditioning/methods , Liver/blood supply , Lung/pathology , Reperfusion Injury/prevention & control , Random Allocation , Rats, Wistar , Reproducibility of Results , Time Factors , Treatment Outcome
2.
Pediatr. mod ; 29(2): 203-4, 206-8, 210-1, abr. 1993. ilus, tab
Article in Portuguese | LILACS | ID: lil-123471

ABSTRACT

Os autores apresentam um caso de Síndrome de Kasabach-Merritt em recém-nascido com quatro dias de vida, tratado com corticoterapia e curativo compressivo. Os resultados obtidos com o tratamento demonstram que a compressäo do hemangioma é uma importante e eficiente medida terapêutica, tanto para elevar o nível plaquetário como para reduzir o tamanho do mesmo. Com referência ao estudo deste tipo de tratamento compressivo, näo foram encontrados relatos semelhantes na literatura


Subject(s)
Humans , Female , Infant, Newborn , Disseminated Intravascular Coagulation/complications , Hemangioma/therapy , Purpura, Thrombocytopenic/therapy , Thrombocytopenia/complications , Thorax/pathology , Adrenal Cortex Hormones/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL